Tustin Local Business

Tustin Local Business

Local business in Tustin, CA

  • Thursday Jul 21 | via TheStreet.com 

    Pool Household Income to Buy a Home with HomeReady

    In most places, it's cheaper to own a home than rent, but that doesn't mean it's easier to get a mortgage than to sign a lease. Now, however, a new federal government mortgage program called HomeReady may open up the possibility of homeownership to a bigger audience.

    Comment?

    Related Topix: Home, Home Buying, Personal Finance, Mortgage, Mortgage, Financial Services, Fannie Mae, Tustin, CA, Business News

  • Apr 30, 2016 | via P&T Community 

    Peregrine Pharmaceuticals Reports Financial Results ...

    Avid Contract Manufacturing Revenues Increased 66% to $44.4 Million with a Revenue Backlog of $68 Million Heading into Fiscal Year 2017 -- -- Analysis of Data from SUNRISE Phase III Trial Ongoing with New Clinical Trials Expected to Commence Late 2016 to Early 2017 -- TUSTIN, Calif., July 14, 2016 -- Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company committed to improving patient lives by delivering high quality biological products through its contract development and manufacturing organization services and by advancing its novel R&D pipeline, today announced financial results for the fourth quarter and fiscal year ended April 30, 2016, and provided an update on its contract manufacturing business, clinical pipeline and other corporate developments.

    Comment?

    Related Topix: Biotech, Peregrine Pharmaceuticals, Tustin, CA

  • Apr 30, 2016 | via P&T Community 

    Peregrine Pharmaceuticals Reports Financial Results ...

    Avid Contract Manufacturing Revenues Increased 66% to $44.4 Million with a Revenue Backlog of $68 Million Heading into Fiscal Year 2017 -- -- Analysis of Data from SUNRISE Phase III Trial Ongoing with New Clinical Trials Expected to Commence Late 2016 to Early 2017 -- TUSTIN, Calif., July 14, 2016 -- Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company committed to improving patient lives by delivering high quality biological products through its contract development and manufacturing organization services and by advancing its novel R&D pipeline, today announced financial results for the fourth quarter and fiscal year ended April 30, 2016, and provided an update on its contract manufacturing business, clinical pipeline and other corporate developments.

    Comment?

    Related Topix: Peregrine Pharmaceuticals, Biotech, Tustin, CA